Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

Lignende værker

• Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study
  af: Calabrese, Leonard H., et al.
  Udgivet: (2020)
• Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
  af: Strand, Vibeke, et al.
  Udgivet: (2016)
• Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
  af: Fleischmann, Roy M, et al.
  Udgivet: (2016)
• Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study
  af: van der Heijde, Désirée, et al.
  Udgivet: (2019)
• Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis
  af: Strand, Vibeke, et al.
  Udgivet: (2016)